Biomarker ID | 1452 |
PMID | 24976077 |
Year | 2014 |
Biomarker | miR-361-3p + miR-361-3p+ mir-221+ mir-203 + mir-133b |
Biomarker Basis | Expression Based |
Biomolecule | miRNA |
Source | Prostate Secretion Samples |
Subjects | Humans |
Regulation | Downregulated in PCa [miR-361-3p; miR-361-3p; mir-221; mir-133b]; Upregulated in PCa: [mir-203] |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | NA |
Experiment | Prostate Cancer Vs Benign Prostatic Hyperplasia |
Type of Biomarker | Diagnostic |
Cohort | Prostate secretion samples (PSS) from 23 PCa and 25 benign prostate hyperplasia (BPH) patients were obtained |
Senstivity | NA |
Specificity | NA |
AUC | 0.95 |
Accuracy | NA |
Level Of Significance | NA |
Method Used | qRT-PCR |
Clinical | No |
Remarks | 4 patients from the cohort were selected for microarray analysis to confirm the results |
Clinical Trial Number | NA |
Degree Of Validity | Not validated on independent patient dataset |
Technical Name | miR-361-3p, mir-221, mir-203, mir-133b |